Page last updated: 2024-12-06

maslinic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Maslinic acid is a pentacyclic triterpene found in the olive tree (Olea europaea) and other plants. It has shown various pharmacological activities, including anti-inflammatory, antioxidant, antiviral, and anticancer effects. Research suggests that maslinic acid may exert its effects through multiple mechanisms, including inhibition of inflammatory pathways, modulation of immune responses, and induction of apoptosis in cancer cells. Its potential therapeutic applications are currently under investigation, and it is being studied for its role in preventing and treating various diseases, such as Alzheimer's disease, diabetes, and cardiovascular disease.'

(2Alpha,3beta)-2,3-dihydroxyolean-12-en-28-oic acid: from Luehea divaricata and Agrimonia eupatoria [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
OleagenusA plant genus of the family Oleaceae. The olive fruit is the source of OLIVE OIL.[MeSH]OleaceaeA plant family of the order Lamiales. The leaves are usually opposite and the flowers usually have four sepals, four petals, two stamens, and two fused carpels that form a single superior ovary.[MeSH]
SalviagenusA genus in the mint family (LAMIACEAE).[MeSH]LamiaceaeThe mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas (united petals), with five-lobed, bell-like calyxes (united sepals).[MeSH]
Olea europaeaspecies[no description available]OleaceaeA plant family of the order Lamiales. The leaves are usually opposite and the flowers usually have four sepals, four petals, two stamens, and two fused carpels that form a single superior ovary.[MeSH]
Salvia canariensisspecies[no description available]LamiaceaeThe mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas (united petals), with five-lobed, bell-like calyxes (united sepals).[MeSH]
Rhodobryum roseumspecies[no description available]Bryaceae[no description available]
Physocarpus intermediusspecies[no description available]RosaceaeThe rose plant family in the order ROSALES and class Magnoliopsida. They are generally woody plants. A number of the species of this family contain cyanogenic compounds.[MeSH]

Cross-References

ID SourceID
PubMed CID73659
CHEMBL ID201515
CHEBI ID66682
SCHEMBL ID570425
MeSH IDM0369040

Synonyms (54)

Synonym
maslic acid
olean-12-en-28-oic acid, 2,3-dihydroxy-, (2alpha,3beta)-
unii-e233j88ohq
hsdb 8099
e233j88ohq ,
(4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2h-picene-4a-carboxylic acid
maslinic acid ,
(4as,6ar,6as,6br,8ar,10r,11r,12ar,14bs)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
olean-12-en-28-oic acid, 2,3-dihydroxy-, (2.alpha.,3.beta.)-
crategolic acid
4373-41-5
emd-1176098
crataegolic acid
C16939
masilinic acid
CHEMBL201515 ,
chebi:66682 ,
bdbm50175892
maslinicacid
2alpha,3beta-dihydroxy-12-oleanen-28-oic acid
2alpha,3beta-dihydroxy-olean-12-en-28-oic acid
AKOS015951204
(2alpha,3beta)-2,3-dihydroxyolean-12-en-28-oic acid
S9040
2.alpha.-hydroxyoleanolic acid
maslinic acid [inci]
SCHEMBL570425
LMPR0106180014
2alpha,3beta-dihydroxyurs-12-en-29-oic acid
CS-3801
AC-33937
Q-101529
maslinic-acid
HY-N0629
mfcd00049293
maslinic acid, analytical standard
2alpha-hydroxyoleanolic acid
(2alpha,3beta)- 2,3-dihydroxy-olean-12-en-28-oate
(2.alpha.,3.beta.)-2,3-dihydroxy-olean-12-en-28-oic acid
(2alpha,3beta)- 2,3-dihydroxy-olean-12-en-28-oic acid
(2.alpha.,3.beta.)-2,3-dihydroxy-olean-12-en-28-oate
maslinic acid, >=98% (hplc)
DTXSID30905074 ,
(r)-4-chloromandelicacid
2a-hydroxyoleanolic acid
2a-hydroxyoleanoic acid
Q1907191
HMS3886H14
CCG-269468
AS-56463
crategolic acid;2-hydroxyoleanolic acid
2alpha-hydroxyoleanoic acid
EX-A6799
dtxcid101334176

Research Excerpts

Overview

Maslinic acid (MA) is a triterpenoid compound of natural abundance in olive plants possessing numerous biological activities. It is a pentacyclic triterpene acid with protective effect on multiple organs against oxidative stress and inflammation.

ExcerptReferenceRelevance
"Maslinic acid (MA) is a pentacyclic triterpene abundant in olive peels. "( Maslinic Acid Attenuates Denervation-Induced Loss of Skeletal Muscle Mass and Strength.
Ferdousi, F; Fukumitsu, S; Isoda, H; Yamauchi, Y, 2021
)
3.51
"Maslinic acid (MA) is a triterpenoid compound of natural abundance in olive plants possessing numerous biological activities. "( Transcriptome and proteome analysis of the antitumor activity of maslinic acid against pancreatic cancer cells.
Kong, L; Sun, L; Wang, C; Zhang, H; Zhang, Y, 2021
)
2.3
"Maslinic acid (MA) is a type of compound with a pentacyclic triterpene structure extracted from olives, and has a strong anti-inflammatory effect and improves metabolic function."( Maslinic Acid Promotes Hypertrophy Induced by Functional Overload in Mouse Skeletal Muscle.
Kubota, K; Shirai, T; Takemasa, T; Uemichi, K; Yamauchi, Y, 2021
)
2.79
"Maslinic acid is a pentacyclic triterpene acid with protective effect on multiple organs against oxidative stress and inflammation."( Maslinic acid activates renal AMPK/SIRT1 signaling pathway and protects against diabetic nephropathy in mice.
Gao, H; Wu, H, 2022
)
2.89
"Maslinic acid (MA) is a pentacyclic triterpenoid acid that is abundant in fruits such as hawthorn and jujube."( Protective effects of maslinic acid on high fat diet-induced liver injury in mice.
Dong, S; Jiang, X; Li, T; Liang, M; Ma, J; Wang, H; Yu, W, 2022
)
1.76
"Maslinic acid (MA) is a phytochemical with anti-inflammatory activity."( Maslinic Acid Suppresses High Glucose-induced Inflammation by Epigenetically Inhibiting TXNIP Expression.
Fan, YF; Li, BR; Sun, WH; Wang, L; Wang, LN, 2022
)
2.89
"Maslinic acid (MA) is a pentacyclic triterpene acid, which exists in many plants, including olive, and is highly safe for human beings. "( Maslinic Acid: A New Compound for the Treatment of Multiple Organ Diseases.
Ding, W; He, Y; Jiao, J; Li, W; Wang, Y; Yang, K; Yang, Y; Zhan, H, 2022
)
3.61
"Maslinic acid (MA) is a natural compound of pentacyclic triterpene acids."( Maslinic acid attenuates UVB-induced oxidative damage in HFF-1 cells.
Cheng, Y; Fan, L; Lu, Z; Luan, X; Luo, D; Wang, Z; Xia, Q, 2023
)
3.07
"Maslinic acid (MA) is a natural pentacyclic triterpenoid with inherent antitumor activity which has a very low solubility in water. "( Maslinic acid solid lipid nanoparticles as hydrophobic anticancer drug carriers: Formulation, in vitro activity and in vivo biodistribution.
Aguilera-Garrido, A; Galisteo-González, F; Gálvez-Ruiz, MJ; Graván, P; Marchal, JA; Medina-O'Donnell, M; Navarro-Marchal, SA; Parra, A, 2023
)
3.8
"Maslinic acid is a naturally occurring dihydroxy, mono-carboxy bioactive triterpenoid. "( Self-assembled renewable nano-sized pentacyclic triterpenoid maslinic acids in aqueous medium for anti-leukemic, antibacterial and biocompatibility studies: An insight into targeted proteins-compound interactions based mechanistic pathway prediction throu
Bag, BG; Banerjee, J; Das, S; Dash, SK; Giri, B; Hasan, SN; Kar, S; Napagoda, M; Patra, S; Pavithra, U; Samanta, S; Wanigasekera, D; Wijesekera, K, 2023
)
2.59
"Maslinic acid is a type of pentacyclic triterpenoid widely found in olives that has good anti-inflammatory activity."( Maslinic acid alleviates LPS-induced mice mastitis by inhibiting inflammatory response, maintaining the integrity of the blood-milk barrier and regulating intestinal flora.
Fu, S; Hu, G; Li, K; Li, S; Li, Y; Liu, J; Ran, X; Wang, X; Yang, Z; Zeng, Y, 2023
)
3.07
"Maslinic acid (MA) is a natural compound distributed in olive fruit."( Maslinic acid prevents IL-1β-induced inflammatory response in osteoarthritis via PI3K/AKT/NF-κB pathways.
Bao, GD; Bian, YJ; Chen, YL; Hu, XL; Hu, ZC; Jin, CQ; Ni, WF; Shen, ZH; Wu, CY; Xuan, JW; Yan, DY, 2021
)
2.79
"Maslinic acid (MA) is a natural triterpene from "( Unveiling the Differential Antioxidant Activity of Maslinic Acid in Murine Melanoma Cells and in Rat Embryonic Healthy Cells Following Treatment with Hydrogen Peroxide.
A Lupiáñez, J; García-Salguero, L; Mokhtari, K; Pérez-Jiménez, A; Rufino-Palomares, EE, 2020
)
2.25
"Maslinic acid is a novel phytochemical reported to target multiple signaling pathways. "( Temporal gene expression profiling of maslinic acid-treated Raji cells.
Goh, HH; Lau, WM; Lim, YM; Subramaniam, M, 2021
)
2.34
"Maslinic acid (MA) is a naturally occurring pentacyclic triterpene known to exert cardioprotective effects. "( In vitro evaluation of the involvement of Nrf2 in maslinic acid-mediated anti-inflammatory effects in atheroma pathogenesis.
Chellappan, DK; Dua, K; Goh, BH; Khaw, KY; Ooi, BK; Phang, SW; Pusparajah, P; Yap, WH; Yong, PVC, 2021
)
2.32
"Maslinic acid (MA) is a component derived from a natural olive-based extract known to have pharmacological functions that include suppressing inflammation. "( Evaluation of maslinic acid with whole-body vibration training in elderly women with knee osteoarthritis.
Fujii, K; Isoda, H; Kanamori, A; Okura, T; Yoon, J, 2018
)
2.28
"Maslinic acid is a pentacyclic triterpene which has potential cardioprotective and anti-inflammatory properties."( Maslinic acid modulates secreted phospholipase A2-IIA (sPLA2-IIA)-mediated inflammatory effects in macrophage foam cells formation.
Ahmed, N; Lim, YM; Ooi, BK; Yap, WH, 2018
)
2.64
"Maslinic acid (MA) is a pentacyclic triterpene with abundance in olive fruit skin and possesses a number of pharmacological actions."( Maslinic acid protects against pressure overload-induced cardiac hypertrophy in mice.
Kong, CY; Liu, YL; Song, P; Tang, QZ; Zhao, XS; Zhou, H, 2018
)
2.64
"Maslinic acid is a pentacyclic triterpene with a plethora of biological activities, including anti-inflammatory, antioxidant, antimicrobial, cardioprotective, and antitumor effects. "( Assessment of the Antiangiogenic and Anti-Inflammatory Properties of a Maslinic Acid Derivative and its Potentiation using Zinc Chloride.
Avram, S; Baderca, F; Cioca, A; Csuk, R; Danciu, C; Dehelean, CA; Mihali, CV; Moacă, EA; Muntean, DM; Pavel, IZ; Pinzaru, I, 2019
)
2.19
"Maslinic acid (MA) is an anti-tumoural agent which shows potent anti-proliferative properties against the HT29 colon-cancer cells. "( Maslinic acid, a triterpenic anti-tumoural agent, interferes with cytoskeleton protein expression in HT29 human colon-cancer cells.
García-Salguero, L; Lupiáñez, JA; Medina, PP; Mokhtari, K; Peragón, J; Reyes-Zurita, FJ; Rufino-Palomares, EE, 2013
)
3.28
"Maslinic acid (MA) is a natural triterpenoid widely distributed in edible and medicinal plants and has been demonstrated to possess bioactivity. "( Maslinic acid protects vascular smooth muscle cells from oxidative stress through Akt/Nrf2/HO-1 pathway.
Qin, X; Qiu, C; Zhao, L, 2014
)
3.29
"Maslinic acid is a bioactive minor component of Olea europaea L. "( Population pharmacokinetics of maslinic acid, a triterpene from olives, after intravenous and oral administration in rats.
Colom, H; Juan, ME; Lozano-Mena, G; Planas, JM; Sánchez-González, M, 2014
)
2.13
"Maslinic acid is a pentacyclic triterpene found in a variety of natural sources, ranging from herbal remedies used in traditional Asian medicine to edible vegetables and fruits present in the Mediterranean diet. "( Maslinic acid, a natural phytoalexin-type triterpene from olives--a promising nutraceutical?
Juan, ME; Lozano-Mena, G; Planas, JM; Sánchez-González, M, 2014
)
3.29
"Maslinic acid (MA) is a pentacyclic triterpene acid that is present in numerous dietary plants. "( Effects of maslinic acid on the proliferation and apoptosis of A549 lung cancer cells.
Bai, X; He, P; Jiang, H; Li, H; Yang, P; Zhang, Y, 2016
)
2.27
"Maslinic acid (MA) is a natural triterpene present in high concentrations in the waxy skin of olives. "( Maslinic Acid, a Natural Triterpene, Induces a Death Receptor-Mediated Apoptotic Mechanism in Caco-2 p53-Deficient Colon Adenocarcinoma Cells.
Cascante, M; García-Salguero, L; Lupiáñez, JA; Medina, PP; Parra, A; Peragón, J; Reyes-Zurita, FJ; Rufino-Palomares, EE, 2016
)
3.32
"Maslinic acid is a natural pentacyclic triterpenoid which has anti-inflammatory properties. "( Inhibition of Human Group IIA-Secreted Phospholipase A2 and THP-1 Monocyte Recruitment by Maslinic Acid.
Ahmed, N; Lim, YM; Yap, WH, 2016
)
2.1
"Maslinic acid (MA) is a natural product with demonstrated pharmacological functions including anti-inflammation, anti-tumor and anti-oxidation, among others."( Target molecules in 3T3-L1 adipocytes differentiation are regulated by maslinic acid, a natural triterpene from Olea europaea.
Fernández-Gallego, N; García-Salguero, L; Lupiáñez, JA; Medina, PP; Mokhtari, K; Ortuño-Costela, MC; Peragón, J; Pérez-Jiménez, A; Reyes-Zurita, FJ; Rufino-Palomares, EE, 2016
)
1.39
"Maslinic acid is a pentacyclic triterpene extracted from olives that has been systematically reported to exert several therapeutic effects, such as antitumoral, antidiabetic, antioxidant, anti-inflammatory, antiparasitic, and antiviral properties. "(
Csuk, R; Danciu, C; Dehelean, CA; Muntean, D; Muntean, DM; Oprean, C; Pavel, IZ, 2016
)
1.88
"Maslinic acid is a novel natural triterpenoid known to inhibit proliferation and induce apoptosis in some tumor cell lines."( Cancer chemopreventive activity of maslinic acid: suppression of COX-2 expression and inhibition of NF-κB and AP-1 activation in Raji cells.
Chieng, YC; Hong, PL; Hoon, LS; Hsum, YW; Mooi, LY; Soo, KK; Yew, WT, 2011
)
1.37
"Maslinic acid (MA) is a triterpenoid with a high concentration that exists in olives. "( Maslinic acid induces apoptosis in salivary gland adenoid cystic carcinoma cells by Ca2+-evoked p38 signaling pathway.
Chu, WF; Li, DZ; Wang, XF; Wu, DM; Xu, DY; Zhao, D, 2011
)
3.25
"Maslinic acid (MA) is a low toxic natural pentacyclic triterpene for which a wide variety of biological and therapeutic activities have been reported."( Multi-targeted activity of maslinic acid as an antimalarial natural compound.
Bautista, JM; Diez, A; Mestres, J; Moneriz, C; Puyet, A, 2011
)
1.39
"Maslinic acid (MA) is a pentacyclic triterpene used as a feed additive to stimulate growth, protein-turnover rates, and hyperplasia in fish. "( Proteomics in the liver of gilthead sea bream (Sparus aurata) to elucidate the cellular response induced by the intake of maslinic acid.
de la Higuera, M; Fuentes-Almagro, CA; Lupiáñez, JA; Peragón, J; Reyes-Zurita, FJ; Rufino-Palomares, E, 2011
)
2.02
"Maslinic acid is a triterpenoid compound present in plants of Olea europaea. "( Maslinic acid, a natural triterpenoid compound from Olea europaea, protects cortical neurons against oxygen-glucose deprivation-induced injury.
Guan, T; Huang, L; Huang, M; Li, Y; Qian, Y; Sun, H; Tang, X, 2011
)
3.25
"Maslinic acid is a triterpene present in a considerable proportion in solid residues from olive-oil production. "( Maslinic acid as a feed additive to stimulate growth and hepatic protein-turnover rates in rainbow trout (Onchorhynchus mykiss).
de la Higuera, M; Esteban, FJ; Fernández-Navarro, M; Lupiáñez, JA; Peragón, J, 2006
)
3.22
"Maslinic acid therefore is a promising new compound for the chemoprevention of colon cancers."( Antiproliferative and apoptosis-inducing effects of maslinic and oleanolic acids, two pentacyclic triterpenes from olives, on HT-29 colon cancer cells.
Daniel, H; Juan, ME; Planas, JM; Ruiz-Gutierrez, V; Wenzel, U, 2008
)
1.07

Effects

Maslinic acid (MA) has been found to regulate pathophysiological processes that mediate programmed cell death in MIRI. It has been described to exert a chemopreventive activity in colon cancer.

ExcerptReferenceRelevance
"Maslinic acid (1) has been coupled at C-28 with several alpha- and omega-amino acids by using solution- and solid-phase synthetic procedures. "( Solution- and solid-phase synthesis and anti-HIV activity of maslinic acid derivatives containing amino acids and peptides.
Albericio, F; Garcia-Granados, A; Lopez, PE; Marquez, N; Martinez, A; Muñoz, E; Parra, A; Rivas, F, 2009
)
2.04
"Maslinic acid (MA) has been found to regulate pathophysiological processes that mediate programmed cell death in MIRI, such as inflammation and oxidative stress."( Maslinic Acid Inhibits Myocardial Ischemia-Reperfusion Injury-Induced Apoptosis and Necroptosis via Promoting Autophagic Flux.
Chen, C; Lei, S; Li, L; Lin, L; Shi, S; Xia, Z, 2022
)
2.89
"Maslinic acid (MA) has been shown to inhibit transcription factor nuclear factor-κB (NF-κB), resulting in the suppression of survival signaling."( Maslinic acid potentiates the antitumor activities of gemcitabine in vitro and in vivo by inhibiting NF-κB-mediated survival signaling pathways in human gallbladder cancer cells.
Jiang, X; Li, B; Wang, J; Xia, N; Yu, Y, 2015
)
2.58
"Maslinic acid has been described to exert a chemopreventive activity in colon cancer. "( Identification of gut-derived metabolites of maslinic acid, a bioactive compound from Olea europaea L.
Juan, ME; Lozano-Mena, G; Parra, A; Planas, JM; Sánchez-González, M, 2016
)
2.14

Treatment

Maslinic acid treatment normalized the caspase expression/activation and increased the Bcl-2/Bax ratio. Pretreatment with maslinic Acid can protect cultured embryonic rat cortical neurons against OGD-induced injury. Co-treatment of maslini acid and MK-801 obviously induced neuroprotection after ischemia.

ExcerptReferenceRelevance
"Maslinic acid treatment alleviated the loss of body weight and blood glucose in diabetic mice. "( Maslinic acid activates renal AMPK/SIRT1 signaling pathway and protects against diabetic nephropathy in mice.
Gao, H; Wu, H, 2022
)
3.61
"Maslinic acid treatment normalized the caspase expression/activation and increased the Bcl-2/Bax ratio."( Maslinic acid, a natural triterpenoid compound from Olea europaea, protects cortical neurons against oxygen-glucose deprivation-induced injury.
Guan, T; Huang, L; Huang, M; Li, Y; Qian, Y; Sun, H; Tang, X, 2011
)
2.53
"Pretreatment with maslinic acid can protect cultured embryonic rat cortical neurons against OGD-induced injury possibly in relation to decreased expression of Bax."( [Protective effect of maslinic acid preconditioning against oxygen-glucose deprivation- induced injuries in embryonic rat cortical neurons].
Han, Y; Huang, B; Li, S; Liu, F; Luo, J; Wu, L, 2013
)
1.04
"Co-treatment of maslinic acid and MK-801 at a subthreshold dosage obviously induced neuroprotection after ischemia."( Neuroprotection by Combined Administration with Maslinic Acid, a Natural Product from Olea europaea, and MK-801 in the Cerebral Ischemia Model.
Guan, T; Li, Y; Qian, Y; Sun, H; Tang, X, 2016
)
1.02

Toxicity

ExcerptReferenceRelevance
"Taken together the results obtained from the acute and the repeated intake of maslinic acid indicate that the compound does not exert any adverse effects on the variables tested in mice, thus suggesting a sufficient margin of safety for its putative use as a nutraceutical."( Assessment of the safety of maslinic acid, a bioactive compound from Olea europaea L.
García-Granados, A; Juan, ME; Lozano-Mena, G; Planas, JM; Sánchez-González, M, 2013
)
0.91
"The clinical applications of some well-known chemotherapeutic drugs for cancer treatment have been restricted nowadays owing to their adverse effects on many physiological systems."( Self-Assembled Maslinic Acid Attenuates Doxorobucin Induced Cytotoxicity via Nrf2 Signaling Pathway: An In Vitro and In Silico Study in Human Healthy Cells.
Bag, BG; Banerjee, J; Dash, SK; Giri, B; Hasan, SN; Samanta, S, 2022
)
1.07

Pharmacokinetics

Maslinic acid had a relative rapid oral absorption with a peak concentration after administration at 0.

ExcerptReferenceRelevance
" A pharmacokinetic (PK) study was conducted to determine its bioavailability for future studies of maslinic acid in humans."( Population pharmacokinetics of maslinic acid, a triterpene from olives, after intravenous and oral administration in rats.
Colom, H; Juan, ME; Lozano-Mena, G; Planas, JM; Sánchez-González, M, 2014
)
0.91

Bioavailability

A pharmacokinetic (PK) study was conducted to determine its bioavailability for future studies of maslinic acid in humans. The method was verified by measuring the rat plasmatic concentrations 24h after the single oral administration of 10, 25 and 50 mg/kg.

ExcerptReferenceRelevance
" Despite its importance, little is known about its bioavailability in both humans and animals."( Determination of maslinic acid, a pentacyclic triterpene from olives, in rat plasma by high-performance liquid chromatography.
García-Granados, A; Juan, ME; Lozano-Mena, G; Planas, JM, 2012
)
0.72
" Finally, the method was verified by measuring the rat plasmatic concentrations 24h after the single oral administration of 10, 25 and 50 mg/kg of maslinic acid, thereby ensuring that the procedure is appropriate for its use in bioavailability studies."( Liquid chromatography-mass spectrometry determination in plasma of maslinic acid, a bioactive compound from Olea europaea L.
García-Granados, A; Juan, ME; Lozano-Mena, G; Planas, JM; Sánchez-González, M, 2013
)
0.83
" A pharmacokinetic (PK) study was conducted to determine its bioavailability for future studies of maslinic acid in humans."( Population pharmacokinetics of maslinic acid, a triterpene from olives, after intravenous and oral administration in rats.
Colom, H; Juan, ME; Lozano-Mena, G; Planas, JM; Sánchez-González, M, 2014
)
0.91
" MA bioavailability was greater than that of OA, and consumption of pentacyclic triterpenes was associated with improved endothelial function."( Pharmacokinetics of maslinic and oleanolic acids from olive oil - Effects on endothelial function in healthy adults. A randomized, controlled, dose-response study.
Biel, S; Carbó, M; Covas, MI; de la Torre, R; Díaz-Pellicer, P; Espejo, JA; Expósito, M; Fitó, M; Jimenez-Valladares, F; Mesa, MD; Pozo, O; Pujadas, M; Rosa, C; Sanchez-Rodriguez, E, 2020
)
0.56
" The bioavailability of 29 was significantly improved in comparison with its aglycon."( Synthesis and anti-inflammatory activity of saponin derivatives of δ-oleanolic acid.
Chen, C; Cheng, K; Dai, L; Hu, K; Li, H; Liu, L; Sun, H; Wen, X; Xu, Q; Yuan, H, 2021
)
0.62

Dosage Studied

ExcerptRelevanceReference
" Co-treatment of maslinic acid and MK-801 at a subthreshold dosage obviously induced neuroprotection after ischemia."( Neuroprotection by Combined Administration with Maslinic Acid, a Natural Product from Olea europaea, and MK-801 in the Cerebral Ischemia Model.
Guan, T; Li, Y; Qian, Y; Sun, H; Tang, X, 2016
)
1.03
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
anti-inflammatory agentAny compound that has anti-inflammatory effects.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
pentacyclic triterpenoid
dihydroxy monocarboxylic acidAny hydroxy monocarboxylic acid carrying at least two hydroxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (19)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AcetylcholinesteraseElectrophorus electricus (electric eel)Ki100.00000.00121.25638.9000AID1286151
Aldo-keto reductase family 1 member B10Homo sapiens (human)IC50 (µMol)0.63000.00101.94459.6000AID697009
Glycogen phosphorylase, muscle formOryctolagus cuniculus (rabbit)IC50 (µMol)28.04590.01405.93249.0000AID404873; AID436293; AID603224
Prostaglandin G/H synthase 1Ovis aries (sheep)IC50 (µMol)42.00000.00032.177410.0000AID1617778
Glycogen phosphorylase, liver formRattus norvegicus (Norway rat)IC50 (µMol)99.00000.68000.92671.1000AID254872
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)IC50 (µMol)40.00000.00011.68479.3200AID1617774
Receptor-type tyrosine-protein phosphatase FHomo sapiens (human)IC50 (µMol)40.00001.30002.66604.2300AID437758
Aldo-keto reductase family 1 member B1Homo sapiens (human)IC50 (µMol)72.00000.00101.191310.0000AID697010
Tyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)IC50 (µMol)19.47000.70004.58049.4500AID437762
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)IC50 (µMol)5.93000.00053.49849.7600AID437763
Tyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)IC50 (µMol)40.00000.29002.20754.2300AID437760
Prostaglandin G/H synthase 2Homo sapiens (human)IC50 (µMol)40.00000.00010.995010.0000AID1617780
CholinesteraseEquus caballus (horse)Ki100.00000.00203.45989.3700AID1286153
Tyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)IC50 (µMol)40.00000.31804.00429.6000AID437759
Protease Human immunodeficiency virus 1IC50 (µMol)62.70000.00000.81769.8500AID1075595
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Egl nine homolog 1Homo sapiens (human)EC50 (µMol)50.00006.11006.11006.1100AID1612308
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (268)

Processvia Protein(s)Taxonomy
retinoid metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
farnesol catabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
cellular detoxification of aldehydeAldo-keto reductase family 1 member B10Homo sapiens (human)
negative regulation of endothelial cell proliferationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukocyte chemotaxis involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukocyte migration involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene production involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene metabolic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
humoral immune responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of angiogenesisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
positive regulation of bone mineralizationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
dendritic cell migrationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
glucose homeostasisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
long-chain fatty acid biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of fat cell differentiationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of insulin secretionPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of vascular wound healingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of wound healingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of inflammatory response to woundingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of cytokine production involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of cellular response to oxidative stressPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene A4 biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of reactive oxygen species biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of response to endoplasmic reticulum stressPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of sprouting angiogenesisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
positive regulation of leukocyte adhesion to arterial endothelial cellPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipoxin biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
cell adhesionReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
cell surface receptor protein tyrosine phosphatase signaling pathwayReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
cell migrationReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
neuron projection regenerationReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
peptidyl-tyrosine dephosphorylationReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
regulation of axon regenerationReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
synaptic membrane adhesionReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
negative regulation of receptor bindingReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
retinoid metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
epithelial cell maturationAldo-keto reductase family 1 member B1Homo sapiens (human)
renal water homeostasisAldo-keto reductase family 1 member B1Homo sapiens (human)
carbohydrate metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
C21-steroid hormone biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
L-ascorbic acid biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
regulation of urine volumeAldo-keto reductase family 1 member B1Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
negative regulation of apoptotic processAldo-keto reductase family 1 member B1Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
fructose biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
cellular hyperosmotic salinity responseAldo-keto reductase family 1 member B1Homo sapiens (human)
metanephric collecting duct developmentAldo-keto reductase family 1 member B1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of cell population proliferationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of tumor necrosis factor-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of lipid storageTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
B cell differentiationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
T cell differentiationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
erythrocyte differentiationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
insulin receptor recyclingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of epidermal growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of tyrosine phosphorylation of STAT proteinTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
glucose homeostasisTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of macrophage differentiationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
positive regulation of gluconeogenesisTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of inflammatory responseTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of T cell receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of chemotaxisTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
regulation of type II interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of type II interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of interleukin-6-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
regulation of hepatocyte growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of interleukin-2-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of interleukin-4-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of macrophage colony-stimulating factor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of positive thymic T cell selectionTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
positive regulation of PERK-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of receptor signaling pathway via JAK-STATTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
positive regulation of JUN kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
actin cytoskeleton organizationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of endocytosisTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of vascular endothelial growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulum unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of intracellular protein transportTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cellular response to unfolded proteinTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor recyclingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of MAP kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STATTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of protein tyrosine kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of hepatocyte growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of PERK-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of receptor catabolic processTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
MAPK cascadeTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
hematopoietic progenitor cell differentiationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of humoral immune response mediated by circulating immunoglobulinTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
G protein-coupled receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
positive regulation of cell population proliferationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of cell population proliferationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of angiogenesisTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
peptidyl-tyrosine phosphorylationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cytokine-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cell differentiationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
platelet formationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
T cell costimulationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of interleukin-6 productionTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of tumor necrosis factor productionTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of mast cell activation involved in immune responseTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
positive regulation of cell adhesion mediated by integrinTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
megakaryocyte developmentTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
T cell proliferationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of T cell proliferationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
natural killer cell mediated cytotoxicityTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
regulation of apoptotic processTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of MAPK cascadeTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
regulation of B cell differentiationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of peptidyl-tyrosine phosphorylationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
T cell receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
B cell receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of T cell receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosolTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
platelet aggregationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of inflammatory response to woundingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
epididymis developmentTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
regulation of G1/S transition of mitotic cell cycleTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
intracellular signal transductionTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
mitotic cell cycleTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 2Homo sapiens (human)
embryo implantationProstaglandin G/H synthase 2Homo sapiens (human)
learningProstaglandin G/H synthase 2Homo sapiens (human)
memoryProstaglandin G/H synthase 2Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell population proliferationProstaglandin G/H synthase 2Homo sapiens (human)
response to xenobiotic stimulusProstaglandin G/H synthase 2Homo sapiens (human)
response to nematodeProstaglandin G/H synthase 2Homo sapiens (human)
response to fructoseProstaglandin G/H synthase 2Homo sapiens (human)
response to manganese ionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 2Homo sapiens (human)
bone mineralizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fever generationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic plasticityProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of synaptic transmission, dopaminergicProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin secretionProstaglandin G/H synthase 2Homo sapiens (human)
response to estradiolProstaglandin G/H synthase 2Homo sapiens (human)
response to lipopolysaccharideProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationProstaglandin G/H synthase 2Homo sapiens (human)
response to vitamin DProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to heatProstaglandin G/H synthase 2Homo sapiens (human)
response to tumor necrosis factorProstaglandin G/H synthase 2Homo sapiens (human)
maintenance of blood-brain barrierProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of protein import into nucleusProstaglandin G/H synthase 2Homo sapiens (human)
hair cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of apoptotic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vasoconstrictionProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
decidualizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle cell proliferationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of inflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
response to glucocorticoidProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of calcium ion transportProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergicProstaglandin G/H synthase 2Homo sapiens (human)
response to fatty acidProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to mechanical stimulusProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to lead ionProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to ATPProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to hypoxiaProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to non-ionic osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to fluid shear stressProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of transforming growth factor beta productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fibroblast growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of platelet-derived growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of neuroinflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to homocysteineProstaglandin G/H synthase 2Homo sapiens (human)
response to angiotensinProstaglandin G/H synthase 2Homo sapiens (human)
DNA damage checkpoint signalingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
triglyceride metabolic processTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
epidermal growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
integrin-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
axonogenesisTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
brain developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
heart developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
fibroblast growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
hormone-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cytokine-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cerebellar cortex formationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
platelet formationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
T cell costimulationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of chondrocyte differentiationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of type I interferon productionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
microvillus organizationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of interferon-beta productionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of interleukin-6 productionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of tumor necrosis factor productionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of cell adhesion mediated by integrinTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of cell adhesion mediated by integrinTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
multicellular organism growthTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
organ growthTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
megakaryocyte developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
atrioventricular canal developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
ERBB signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
hormone metabolic processTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
glucose homeostasisTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of protein-containing complex assemblyTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of ossificationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of mitotic cell cycleTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of glucose importTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of insulin secretionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of protein export from nucleusTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of hormone secretionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
platelet-derived growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
neurotrophin TRK receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
ephrin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
multicellular organismal reproductive processTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
genitalia developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
inner ear developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
homeostasis of number of cells within a tissueTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of cortisol secretionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
Bergmann glial cell differentiationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of growth hormone secretionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
face morphogenesisTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
intestinal epithelial cell migrationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cellular response to epidermal growth factor stimulusTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of cell growthProlyl hydroxylase EGLN2Homo sapiens (human)
response to hypoxiaProlyl hydroxylase EGLN2Homo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineProlyl hydroxylase EGLN2Homo sapiens (human)
intracellular estrogen receptor signaling pathwayProlyl hydroxylase EGLN2Homo sapiens (human)
regulation of neuron apoptotic processProlyl hydroxylase EGLN2Homo sapiens (human)
cell redox homeostasisProlyl hydroxylase EGLN2Homo sapiens (human)
positive regulation of protein catabolic processProlyl hydroxylase EGLN2Homo sapiens (human)
cellular response to hypoxiaProlyl hydroxylase EGLN2Homo sapiens (human)
response to hypoxiaEgl nine homolog 1Homo sapiens (human)
intracellular iron ion homeostasisEgl nine homolog 1Homo sapiens (human)
intracellular oxygen homeostasisEgl nine homolog 1Homo sapiens (human)
negative regulation of DNA-binding transcription factor activityEgl nine homolog 1Homo sapiens (human)
regulation of angiogenesisEgl nine homolog 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIEgl nine homolog 1Homo sapiens (human)
negative regulation of cyclic-nucleotide phosphodiesterase activityEgl nine homolog 1Homo sapiens (human)
cardiac muscle tissue morphogenesisEgl nine homolog 1Homo sapiens (human)
heart trabecula formationEgl nine homolog 1Homo sapiens (human)
ventricular septum morphogenesisEgl nine homolog 1Homo sapiens (human)
labyrinthine layer developmentEgl nine homolog 1Homo sapiens (human)
response to nitric oxideEgl nine homolog 1Homo sapiens (human)
regulation of modification of postsynaptic structureEgl nine homolog 1Homo sapiens (human)
regulation protein catabolic process at postsynapseEgl nine homolog 1Homo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineEgl nine homolog 1Homo sapiens (human)
cellular response to hypoxiaEgl nine homolog 1Homo sapiens (human)
response to hypoxiaProlyl hydroxylase EGLN3Homo sapiens (human)
apoptotic processProlyl hydroxylase EGLN3Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processProlyl hydroxylase EGLN3Homo sapiens (human)
DNA damage responseProlyl hydroxylase EGLN3Homo sapiens (human)
protein hydroxylationProlyl hydroxylase EGLN3Homo sapiens (human)
regulation of cell population proliferationProlyl hydroxylase EGLN3Homo sapiens (human)
regulation of neuron apoptotic processProlyl hydroxylase EGLN3Homo sapiens (human)
cellular response to hypoxiaProlyl hydroxylase EGLN3Homo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineProlyl hydroxylase EGLN3Homo sapiens (human)
regulation of erythrocyte differentiationTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (62)

Processvia Protein(s)Taxonomy
retinal dehydrogenase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
aldo-keto reductase (NADPH) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
protein bindingAldo-keto reductase family 1 member B10Homo sapiens (human)
alcohol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
geranylgeranyl reductase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
indanol dehydrogenase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
arachidonate 5-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonate 12(S)-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
iron ion bindingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
protein bindingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
hydrolase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
protein tyrosine phosphatase activityReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
transmembrane receptor protein tyrosine phosphatase activityReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
heparin bindingReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
chondroitin sulfate proteoglycan bindingReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
protein-containing complex bindingReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
cell adhesion molecule bindingReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
retinal dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
protein bindingAldo-keto reductase family 1 member B1Homo sapiens (human)
electron transfer activityAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin H2 endoperoxidase reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glyceraldehyde oxidoreductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
L-glucuronate reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glycerol dehydrogenase [NADP+] activityAldo-keto reductase family 1 member B1Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
integrin bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
syntaxin bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
STAT family protein bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
RNA bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
zinc ion bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
enzyme bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cadherin bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
ephrin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein phosphatase 2A bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
phosphotyrosine residue bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
transmembrane receptor protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
SH3 domain bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
SH2 domain bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cell adhesion molecule bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
phosphorylation-dependent protein bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
peroxidase activityProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 2Homo sapiens (human)
protein bindingProstaglandin G/H synthase 2Homo sapiens (human)
enzyme bindingProstaglandin G/H synthase 2Homo sapiens (human)
heme bindingProstaglandin G/H synthase 2Homo sapiens (human)
protein homodimerization activityProstaglandin G/H synthase 2Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 2Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 2Homo sapiens (human)
phosphotyrosine residue bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
phosphoprotein phosphatase activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
insulin receptor bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
signaling receptor complex adaptor activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cadherin bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cell adhesion molecule bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
peptide hormone receptor bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
molecular adaptor activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein bindingProlyl hydroxylase EGLN2Homo sapiens (human)
ferrous iron bindingProlyl hydroxylase EGLN2Homo sapiens (human)
2-oxoglutarate-dependent dioxygenase activityProlyl hydroxylase EGLN2Homo sapiens (human)
oxygen sensor activityProlyl hydroxylase EGLN2Homo sapiens (human)
L-ascorbic acid bindingProlyl hydroxylase EGLN2Homo sapiens (human)
peptidyl-proline 4-dioxygenase activityProlyl hydroxylase EGLN2Homo sapiens (human)
hypoxia-inducible factor-proline dioxygenase activityProlyl hydroxylase EGLN2Homo sapiens (human)
protein bindingEgl nine homolog 1Homo sapiens (human)
ferrous iron bindingEgl nine homolog 1Homo sapiens (human)
2-oxoglutarate-dependent dioxygenase activityEgl nine homolog 1Homo sapiens (human)
enzyme bindingEgl nine homolog 1Homo sapiens (human)
L-ascorbic acid bindingEgl nine homolog 1Homo sapiens (human)
peptidyl-proline dioxygenase activityEgl nine homolog 1Homo sapiens (human)
hypoxia-inducible factor-proline dioxygenase activityEgl nine homolog 1Homo sapiens (human)
peptidyl-proline 4-dioxygenase activityEgl nine homolog 1Homo sapiens (human)
protein bindingProlyl hydroxylase EGLN3Homo sapiens (human)
2-oxoglutarate-dependent dioxygenase activityProlyl hydroxylase EGLN3Homo sapiens (human)
L-ascorbic acid bindingProlyl hydroxylase EGLN3Homo sapiens (human)
peptidyl-proline 4-dioxygenase activityProlyl hydroxylase EGLN3Homo sapiens (human)
hypoxia-inducible factor-proline dioxygenase activityProlyl hydroxylase EGLN3Homo sapiens (human)
ferrous iron bindingProlyl hydroxylase EGLN3Homo sapiens (human)
iron ion bindingTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
calcium ion bindingTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
2-oxoglutarate-dependent dioxygenase activityTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
L-ascorbic acid bindingTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
hypoxia-inducible factor-proline dioxygenase activityTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
procollagen-proline 4-dioxygenase activityTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (42)

Processvia Protein(s)Taxonomy
extracellular regionAldo-keto reductase family 1 member B10Homo sapiens (human)
lysosomeAldo-keto reductase family 1 member B10Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B10Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B10Homo sapiens (human)
mitochondrionAldo-keto reductase family 1 member B10Homo sapiens (human)
extracellular regionPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
extracellular spacePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelopePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelope lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nucleoplasmPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
cytosolPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear matrixPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear membranePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
secretory granule lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
perinuclear region of cytoplasmPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
ficolin-1-rich granule lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelopePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
plasma membraneReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
neuron projectionReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
neuronal cell bodyReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
extracellular exosomeReceptor-type tyrosine-protein phosphatase FHomo sapiens (human)
extracellular spaceAldo-keto reductase family 1 member B1Homo sapiens (human)
nucleoplasmAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
extracellular exosomeAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
plasma membraneTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
nucleoplasmTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
endosome lumenTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
nucleusTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
plasma membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial matrixTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial cristaTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endosome lumenTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
sorting endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmic side of endoplasmic reticulum membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
plasma membraneTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
extracellular regionTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
nucleusTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
nucleoplasmTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
nucleolusTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cell-cell junctionTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
membraneTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
specific granule lumenTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
extracellular exosomeTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
tertiary granule lumenTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
alpha-beta T cell receptor complexTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
nuclear inner membraneProstaglandin G/H synthase 2Homo sapiens (human)
nuclear outer membraneProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulumProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum lumenProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 2Homo sapiens (human)
caveolaProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
protein-containing complexProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
nucleusTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
nucleoplasmTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
nucleusProlyl hydroxylase EGLN2Homo sapiens (human)
nucleoplasmProlyl hydroxylase EGLN2Homo sapiens (human)
nucleusProlyl hydroxylase EGLN2Homo sapiens (human)
cytoplasmProlyl hydroxylase EGLN2Homo sapiens (human)
cytoplasmEgl nine homolog 1Homo sapiens (human)
cytosolEgl nine homolog 1Homo sapiens (human)
postsynaptic densityEgl nine homolog 1Homo sapiens (human)
intracellular membrane-bounded organelleEgl nine homolog 1Homo sapiens (human)
glutamatergic synapseEgl nine homolog 1Homo sapiens (human)
nucleusEgl nine homolog 1Homo sapiens (human)
cytoplasmEgl nine homolog 1Homo sapiens (human)
nucleusProlyl hydroxylase EGLN3Homo sapiens (human)
nucleoplasmProlyl hydroxylase EGLN3Homo sapiens (human)
cytoplasmProlyl hydroxylase EGLN3Homo sapiens (human)
cytosolProlyl hydroxylase EGLN3Homo sapiens (human)
cytoplasmProlyl hydroxylase EGLN3Homo sapiens (human)
nucleusProlyl hydroxylase EGLN3Homo sapiens (human)
endoplasmic reticulum membraneTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
endoplasmic reticulumTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (263)

Assay IDTitleYearJournalArticle
AID1347400Viability qHTS for inhibitors of the SERCaMP assay screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347391qHTS for activators of Nrf2/ARE signaling pathway screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347347UWB1.289 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347354UWB1.289-WTBRCA1 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347370qHTS for ATAD5 Antagonist screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347401Redox Reaction Profiling qHTS: Assay Interference Panel against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347368G06 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347366KB-3-1 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347351U-118MG Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347371J3T Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347349Panc-1005 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347360HPAF-II 18hr Apoptosis Induction qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347364KB-8-5-11 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347389qHTS assay for small molecule disruptors of mitochondrial membrane potential screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347363Firefly luciferase counterscreen qHTS: Assay Interference Panel against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347373qHTS for Constitutive Androstane Receptor (CAR) Agonist screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347374qHTS for Hypoxia signaling pathway (HIF-1) antagonists against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347396qHTS for inhibitors of Wild type Zika virus screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347352COV-362 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347379qHTS for Inflammasome Signaling Inhibitors: IL-1-beta AlphaLISA screen against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347392qHTS for activators of dead-cell proteases activity screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID134737610-beta competent E. coli microbial cell viability qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347372qHTS for Constitutive Androstane Receptor (CAR) Antagonist screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347387Cytotoxicity qHTS for assessment of Hepg2 cells membrane integrity screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347348OV-SAHO Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347388qHTS for Activators of p53 Stress Response Pathway screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347390Secretion counterscreen for inhibitors of the SERCaMP assay screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347375qHTS for Hypoxia signaling pathway (HIF-1) agonists against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347356HPAF-II 24hr Apoptosis Induction qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347361HEK293 12hr Apoptosis Induction qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347402qHTS for inhibitors of Rabies Virus screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347359HEK293 24hr Apoptosis Induction qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347394Vero-766 cells viability qHTS against the NCATS CANVASS Library: Counterscreen for Zika virus inhibition assay2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347369MCF7 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347380qHTS for Antimalaria activity screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347365SDT Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347350SW1088 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347393qHTS for inhibitors of ER calcium dysfunction: SERCaMP assay screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347381Inflammasome Signaling qHTS Counterscreen: IL-1-beta AlphaLISA counterscreen against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347358HPAF-II 12hr Apoptosis Induction qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347355HEK-293 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347367qHTS for ATAD5 Agonist screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347362Diaphorse counterscreen qHTS: Assay Interference Panel against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347377DH5-alpha competent E. coli microbial cell viability qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347378qHTS for H2AX Agonists against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347353A2780 Cisplatin Sensitive Ovarian Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347346HPAF-II Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347357HEK293 18hr Apoptosis Induction qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347345OV-KATE Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1745854NCATS anti-infectives library activity on HEK293 viability as a counter-qHTS vs the C. elegans viability qHTS2023Disease models & mechanisms, 03-01, Volume: 16, Issue:3
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
AID1745855NCATS anti-infectives library activity on the primary C. elegans qHTS viability assay2023Disease models & mechanisms, 03-01, Volume: 16, Issue:3
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
AID1347411qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1055269Induction of apoptosis in human HT-29 cells assessed as secondary necrosis at 30 uM after 6 hrs by annexin V/propidium iodide staining-based FACS analysis2013European journal of medicinal chemistry, , Volume: 70Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28.
AID1435535Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-6 production at 2 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID254893Inhibitory concentration against rabbit muscle glycogen phosphorylase2005Bioorganic & medicinal chemistry letters, Nov-15, Volume: 15, Issue:22
Pentacyclic triterpenes. Part 1: the first examples of naturally occurring pentacyclic triterpenes as a new class of inhibitors of glycogen phosphorylases.
AID697011Selectivity ratio of IC50 for human recombinant AKR1B1 to IC50 for human AKR1B102011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID603224Inhibition of rabbit muscle glycogen phosphorylase A assessed as release of phosphate from glucose-1-phosphate after 25 mins by microplate reader based method2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Identification of pentacyclic triterpenes derivatives as potent inhibitors against glycogen phosphorylase based on 3D-QSAR studies.
AID1246450Antiinflammatory activity in IRC mouse assessed as inhibition of TPA-induced IL-1beta mRNA expression in epidermis at 2 umol administered topically 30 mins prior to TPA challenge for twice weekly over 2 weeks measured 6 hrs post last TPA challenge by qRT-2015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Synthesis of oxygenated oleanolic and ursolic acid derivatives with anti-inflammatory properties.
AID1377061Inhibition of BMI1 promoter (unknown origin) expressed in HEK293T cells after 24 hrs by luciferase reporter gene assay2017Journal of natural products, 06-23, Volume: 80, Issue:6
Identification of BMI1 Promoter Inhibitors from Beaumontia murtonii and Eugenia operculata.
AID1364713Cytotoxicity in mouse BV2 cells assessed as cell viability at 20 uM incubated for 24 hrs by MTT assay relative to untreated control2017Journal of natural products, 04-28, Volume: 80, Issue:4
Bioactive Triterpenoids from the Twigs of Chaenomeles sinensis.
AID1055275Induction of apoptosis in human HT-29 cells at 30 uM after 24 to 48 hrs by acridine orange/propidium iodide dye exclusion assay2013European journal of medicinal chemistry, , Volume: 70Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28.
AID1075595Inhibition of HIV1 recombinant protease expressed in Escherichia coli using Abz-Ala-Arg-Val-Nle-Tyr(NO2)-Glu-Ala-Nle-NH2 as substrate by FRET assay2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID1055285Cell cycle arrest in human HT-29 cells assessed as accumulation at G1/G0 phase at 30 uM after 24 to 48 hrs by propidium iodide staining-based FACS analysis2013European journal of medicinal chemistry, , Volume: 70Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28.
AID1628354Cytotoxicity against human MCF7 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay2016European journal of medicinal chemistry, Aug-25, Volume: 119Urea derivates of ursolic, oleanolic and maslinic acid induce apoptosis and are selective cytotoxic for several human tumor cell lines.
AID1443717Cytotoxicity against human Lu1 cells assessed as growth inhibition after 72 hrs by neutral red assay2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Cytotoxic dammarane-type triterpenoids from the leaves of Viburnum sambucinum.
AID1404180Cytotoxicity against MDCK cells assessed as decrease in cell viability after 72 hrs
AID1055288Cytotoxicity against human A2780 cells after 96 hrs by SRB assay2013European journal of medicinal chemistry, , Volume: 70Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28.
AID480907Antimicrobial activity against Toxoplasma gondii RH tachyzoites assessed as inhibition of parasite invasion of african green monkey Vero cells pretreated for 1 hr before cell infection measured 24 to 48 hrs post infection2010Journal of natural products, May-28, Volume: 73, Issue:5
Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii.
AID368221Cell cycle arrest in HIV1 NL4-3 infected human MT2 cells assessed as accumulation at S phase at 25 uM administered 30 mins before viral challenge measured after 24 hrs by propidium iodide staining and flow cytometry2009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Solution- and solid-phase synthesis and anti-HIV activity of maslinic acid derivatives containing amino acids and peptides.
AID735855Antinociceptive activity in CD-1 mouse assessed as reduction of formalin-induced inflammatory pain at 1 % administered topically 15 mins challenge measured after 10 to 50 mins2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Antiallodynic and analgesic effects of maslinic acid, a pentacyclic triterpenoid from Olea europaea.
AID1383852Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by sulforhodamine-B assay2018European journal of medicinal chemistry, Apr-25, Volume: 150An access to a library of novel triterpene derivatives with a promising pharmacological potential by Ugi and Passerini multicomponent reactions.
AID437762Inhibition of GST-tagged human TCPTP2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Synthesis and biological evaluation of heterocyclic ring-substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
AID1055265Induction of apoptosis in human HT-29 cells assessed as caspase-8 activation at 30 uM after 12 hrs by colorimetric assay2013European journal of medicinal chemistry, , Volume: 70Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28.
AID1435541Cytotoxicity against mouse RAW264.7 cells assessed as growth inhibition at 10 uM after 72 hrs by MTT assay relative to control2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID1570137Anticancer activity against human 8505C cells measured after 96 hrs by sulforhodamine B assay2019European journal of medicinal chemistry, Oct-15, Volume: 1802-O-(2-chlorobenzoyl) maslinic acid triggers apoptosis in A2780 human ovarian carcinoma cells.
AID1570144Anticancer activity against human SW1736 cells measured after 96 hrs by sulforhodamine B assay2019European journal of medicinal chemistry, Oct-15, Volume: 1802-O-(2-chlorobenzoyl) maslinic acid triggers apoptosis in A2780 human ovarian carcinoma cells.
AID1728066Activation of AMPK in human Huh-7 cells assessed as increase in AMPK phosphorylation at Thr172 residue at 10 uM measured after 12 hrs by Western blot analysis2021European journal of medicinal chemistry, Jan-01, Volume: 209Synthesis and anti-inflammatory activity of saponin derivatives of δ-oleanolic acid.
AID682477Induction of apoptosis in human 8505C cells assessed as induction of cell death after 24 to 48 hrs by AO/PI exclusion dye assay2012European journal of medicinal chemistry, Oct, Volume: 56Tormentic acid derivatives: synthesis and apoptotic activity.
AID1074869Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Mar-03, Volume: 74Membrane damaging activity of a maslinic acid analog.
AID1628358Cytotoxicity against mouse NIH/3T3 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay2016European journal of medicinal chemistry, Aug-25, Volume: 119Urea derivates of ursolic, oleanolic and maslinic acid induce apoptosis and are selective cytotoxic for several human tumor cell lines.
AID480917Cytopathic effect against Toxoplasma gondii RH intracellular tachyzoites infected in african green monkey Vero cells assessed as induction of morphological changes at 25 uM by electron microscopy2010Journal of natural products, May-28, Volume: 73, Issue:5
Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii.
AID1456044Inhibition of RANKL-induced C57BL/6 mouse bone marrow monocytes differentiation into osteoclasts at 2 uM after 6 days in presence of M-CSF by tartrate-resistant acid phosphatase staining based assay relative to control2017European journal of medicinal chemistry, May-05, Volume: 131Synthesis of heterocyclic ring-fused tricyclic diterpene analogs as novel inhibitors of RANKL-induced osteoclastogenesis and bone resorption.
AID1617778Inhibition of ovine recombinant COX1 assessed as decrease in formation of PGE2 using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1431434Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1383847Cytotoxicity against human MCF7 cells after 96 hrs by sulforhodamine-B assay2018European journal of medicinal chemistry, Apr-25, Volume: 150An access to a library of novel triterpene derivatives with a promising pharmacological potential by Ugi and Passerini multicomponent reactions.
AID1422363Cytotoxicity against human 8505C cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID480912Antimicrobial activity against Toxoplasma gondii RH tachyzoites assessed as inhibition of parasite gliding motility pretreated for 15 mins2010Journal of natural products, May-28, Volume: 73, Issue:5
Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii.
AID260787Inhibitory activity against rabbit muscle GPa2006Bioorganic & medicinal chemistry letters, Feb, Volume: 16, Issue:3
Pentacyclic triterpenes. Part 2: Synthesis and biological evaluation of maslinic acid derivatives as glycogen phosphorylase inhibitors.
AID1383851Cytotoxicity against human FADU cells after 96 hrs by sulforhodamine-B assay2018European journal of medicinal chemistry, Apr-25, Volume: 150An access to a library of novel triterpene derivatives with a promising pharmacological potential by Ugi and Passerini multicomponent reactions.
AID1383848Cytotoxicity against human 518A2 cells after 96 hrs by sulforhodamine-B assay2018European journal of medicinal chemistry, Apr-25, Volume: 150An access to a library of novel triterpene derivatives with a promising pharmacological potential by Ugi and Passerini multicomponent reactions.
AID1570151Induction of apoptosis in human A2780 cells assessed as autophagy mediated cell death at 30 uM measured after 24 to 72 hrs by annexin v flow cytometry analysis2019European journal of medicinal chemistry, Oct-15, Volume: 1802-O-(2-chlorobenzoyl) maslinic acid triggers apoptosis in A2780 human ovarian carcinoma cells.
AID1075588Induction of apoptosis in mouse B16F10 cells assessed as late apoptotic cells at 2 X IC50 after 72 hrs by annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 9.8 +/- 2.2%)2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID338353Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as early antigen activation at 10 mol ratio after 48 hrs relative to TPA
AID480915Cytopathic effect against Toxoplasma gondii RH extracellular tachyzoites infected in african green monkey Vero cells assessed as induction of morphological changes at 25 uM after 4 hrs by electron microscopy2010Journal of natural products, May-28, Volume: 73, Issue:5
Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii.
AID1286151Inhibition of Electrophorus electricus AChE using acetylthiocholine iodide as substrate preincubated for 20mins before the addition of substrate by Ellman's method2015European journal of medicinal chemistry, Oct-20, Volume: 103Converting maslinic acid into an effective inhibitor of acylcholinesterases.
AID1873260Anti-obesity activity in male C57BL/6 mouse model of high-fat diet induced obesity assessed as body weight change at 20 mg/kg, ip administered twice a week for 12 weeks relative to control2022European journal of medicinal chemistry, Jul-05, Volume: 237Recent advances in natural anti-obesity compounds and derivatives based on in vivo evidence: A mini-review.
AID338356Cytotoxicity against human Raji cells assessed as cell viability at 1000 mol ratio after 48 hrs relative to TPA
AID368223Cell cycle arrest in HIV1 NL4-3 infected human MT2 cells assessed as accumulation at G2/M phase at 25 uM administered 30 mins before viral challenge measured after 24 hrs by propidium iodide staining and flow cytometry2009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Solution- and solid-phase synthesis and anti-HIV activity of maslinic acid derivatives containing amino acids and peptides.
AID437763Inhibition of GST-tagged human PTP 1B2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Synthesis and biological evaluation of heterocyclic ring-substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
AID1066419Cytotoxicity against human A2780 cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Jan-24, Volume: 72The chemical and biological potential of C ring modified triterpenoids.
AID404873Inhibition of rabbit muscle glycogen phosphorylase A assessed as phosphate release from glucose-1-phosphate2008Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies.
AID1074868Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Mar-03, Volume: 74Membrane damaging activity of a maslinic acid analog.
AID1383846Cytotoxicity against human HT-29 cells after 96 hrs by sulforhodamine-B assay2018European journal of medicinal chemistry, Apr-25, Volume: 150An access to a library of novel triterpene derivatives with a promising pharmacological potential by Ugi and Passerini multicomponent reactions.
AID480908Toxicity in african green monkey Vero cells by alamar blue assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii.
AID1617781Inhibition of human recombinant COX2 expressed in baculovirus infected sf21 cells assessed as residual activity at 42 uM using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis r2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID437759Inhibition of GST-tagged human SHP22009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Synthesis and biological evaluation of heterocyclic ring-substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
AID437764Inhibition of glycogen phosphorylase2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Synthesis and biological evaluation of heterocyclic ring-substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
AID1286153Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 20mins before the addition of substrate by Ellman's method2015European journal of medicinal chemistry, Oct-20, Volume: 103Converting maslinic acid into an effective inhibitor of acylcholinesterases.
AID377417Inhibition of prostaglandin E1-induced contraction in Hartley guinea pig ileum at 39 umol by modified Magnus assay2006Journal of natural products, Jul, Volume: 69, Issue:7
Diterpenes from Leucas aspera inhibiting prostaglandin-induced contractions.
AID1617776Inhibition of human recombinant N-terminal His-tagged 15-LOX2 expressed in Escherichia coli using arachidonic acid as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in dark by ferric ion oxidation-xylenol orange as2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1617774Inhibition of human recombinant 5-LOX expressed in insect cells assessed as decrease in production of 5-HPETE and 5-HETE using arachidonic acid as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in dark by ferric io2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1364712Anti-inflammatory in mouse BV2 cells assessed as inhibition of LPS-induced nitric oxide production pre-incubated before LPS challenge for 24 hrs by Griess reagent based assay2017Journal of natural products, 04-28, Volume: 80, Issue:4
Bioactive Triterpenoids from the Twigs of Chaenomeles sinensis.
AID480919Antimicrobial activity against Toxoplasma gondii RH tachyzoites assessed as inhibition of parasite gliding motility at 25 uM pretreated for 15 mins2010Journal of natural products, May-28, Volume: 73, Issue:5
Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii.
AID1456047Inhibition of RANKL-induced C57BL/6 mouse bone marrow monocytes differentiation into osteoclasts after 6 days in presence of M-CSF by tartrate-resistant acid phosphatase staining based assay2017European journal of medicinal chemistry, May-05, Volume: 131Synthesis of heterocyclic ring-fused tricyclic diterpene analogs as novel inhibitors of RANKL-induced osteoclastogenesis and bone resorption.
AID338355Cytotoxicity against human Raji cells assessed as cell viability at 5000 mol ratio after 48 hrs relative to TPA
AID1066416Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Jan-24, Volume: 72The chemical and biological potential of C ring modified triterpenoids.
AID1570138Anticancer activity against human A253 cells measured after 96 hrs by sulforhodamine B assay2019European journal of medicinal chemistry, Oct-15, Volume: 1802-O-(2-chlorobenzoyl) maslinic acid triggers apoptosis in A2780 human ovarian carcinoma cells.
AID1443719Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by neutral red assay2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Cytotoxic dammarane-type triterpenoids from the leaves of Viburnum sambucinum.
AID1382750Growth inhibition of human HT-29 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Mar-25, Volume: 148Diamine and PEGylated-diamine conjugates of triterpenic acids as potential anticancer agents.
AID1055281Cell cycle arrest in human HT-29 cells assessed as total reduction of cells in S phase at 30 uM after 48 hrs by propidium iodide staining-based FACS analysis2013European journal of medicinal chemistry, , Volume: 70Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28.
AID377420Inhibition of prostaglandin E2-induced contraction in Hartley guinea pig ileum at 64 umol by modified Magnus assay2006Journal of natural products, Jul, Volume: 69, Issue:7
Diterpenes from Leucas aspera inhibiting prostaglandin-induced contractions.
AID1383849Cytotoxicity against human A2780 cells after 96 hrs by sulforhodamine-B assay2018European journal of medicinal chemistry, Apr-25, Volume: 150An access to a library of novel triterpene derivatives with a promising pharmacological potential by Ugi and Passerini multicomponent reactions.
AID587675Antibacterial activity against Escherichia coli assessed as growth inhibition by liquid microdilution assay2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Triterpenoid saponins from Symplocos lancifolia.
AID338352Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as early antigen activation at 100 mol ratio after 48 hrs relative to TPA
AID1075584Induction of apoptosis in mouse B16F10 cells assessed as necrotic cells at 2 X IC50 after 72 hrs by annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 4.0 +/- 0.6%)2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID368214Antiviral activity against HIV1 NL4-3 infected human MT2 cells assessed as viral infection at 10 uM administered 30 mins before viral challenge by luciferase reporter gene activation assay relative to control2009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Solution- and solid-phase synthesis and anti-HIV activity of maslinic acid derivatives containing amino acids and peptides.
AID1776684Cytotoxicity against human HT-29 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay2021Journal of natural products, 05-28, Volume: 84, Issue:5
Synthesis and Biological Activity of Triterpene-Coumarin Conjugates.
AID1310454Cytotoxicity against human HT-29 cells assessed as growth inhibition after 72 hrs by MTT assay2016European journal of medicinal chemistry, Aug-08, Volume: 118Semi-synthesis and antiproliferative evaluation of PEGylated pentacyclic triterpenes.
AID1570136Anticancer activity against human 518A2 cells measured after 96 hrs by sulforhodamine B assay2019European journal of medicinal chemistry, Oct-15, Volume: 1802-O-(2-chlorobenzoyl) maslinic acid triggers apoptosis in A2780 human ovarian carcinoma cells.
AID1075589Induction of apoptosis in mouse B16F10 cells assessed as late apoptotic cells at IC50 after 72 hrs by annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 9.8 +/- 2.2%)2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID480911Antimicrobial activity against Toxoplasma gondii RH tachyzoites assessed as inhibition of parasite gliding motility at 50 uM pretreated for 15 mins2010Journal of natural products, May-28, Volume: 73, Issue:5
Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii.
AID1431435Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID368215Antiviral activity against HIV1 NL4-3 infected human MT2 cells assessed as viral infection at 25 uM administered 30 mins before viral challenge by luciferase reporter gene activation assay relative to control2009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Solution- and solid-phase synthesis and anti-HIV activity of maslinic acid derivatives containing amino acids and peptides.
AID1435540Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha production at 0.4 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID1435530Cytotoxicity against human NCI-N87 cells after 72 hrs by MTT assay2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID1066420Cytotoxicity against human 8505C cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Jan-24, Volume: 72The chemical and biological potential of C ring modified triterpenoids.
AID437760Inhibition of GST-tagged human SHP12009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Synthesis and biological evaluation of heterocyclic ring-substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
AID1075587Induction of apoptosis in mouse B16F10 cells assessed as total apoptotic cells at IC50 after 72 hrs by annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 13.7 +/- 2.7%)2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID1435538Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha production at 10 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID1431437Cytotoxicity against human 8505C cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1074872Cytotoxicity against human A2780 cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Mar-03, Volume: 74Membrane damaging activity of a maslinic acid analog.
AID1074871Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Mar-03, Volume: 74Membrane damaging activity of a maslinic acid analog.
AID338350Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as early antigen activation at 5000 mol ratio after 48 hrs relative to TPA
AID254872Inhibitory concentration against rat liver glycogen phosphorylase2005Bioorganic & medicinal chemistry letters, Nov-15, Volume: 15, Issue:22
Pentacyclic triterpenes. Part 1: the first examples of naturally occurring pentacyclic triterpenes as a new class of inhibitors of glycogen phosphorylases.
AID1074874Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Mar-03, Volume: 74Membrane damaging activity of a maslinic acid analog.
AID587674Antibacterial activity against Enterococcus faecalis assessed as growth inhibition by liquid microdilution assay2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Triterpenoid saponins from Symplocos lancifolia.
AID1066415Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Jan-24, Volume: 72The chemical and biological potential of C ring modified triterpenoids.
AID1634718Antibacterial activity against Bacillus thuringiensis measured after 5 to 6 hrs by microdilution titre technique2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID1422362Cytotoxicity against human A549 cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID1075592Induction of apoptosis in mouse B16F10 cells assessed as normal cells at IC50 after 72 hrs by annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 77.9 +/- 1.5%)2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID368216Induction of apoptosis in HIV1 NL4-3 infected human MT2 cells at 10 uM administered 30 mins before viral challenge measured after 24 hrs by propidium iodide staining and flow cytometry2009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Solution- and solid-phase synthesis and anti-HIV activity of maslinic acid derivatives containing amino acids and peptides.
AID1075590Induction of apoptosis in mouse B16F10 cells assessed as early apoptotic cells at 2 X IC50 after 72 hrs by annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 3.9 +/- 0.4%)2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID750462Antiviral activity against pseudo HCV infected in human 293T cells assessed as inhibition of HCV pseudo particles entry at 10 uM after 72 hrs by luciferase reporter gene assay2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Development of oleanane-type triterpenes as a new class of HCV entry inhibitors.
AID1422357Cytotoxicity against human A2780 cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID1628353Cytotoxicity against human HT-29 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay2016European journal of medicinal chemistry, Aug-25, Volume: 119Urea derivates of ursolic, oleanolic and maslinic acid induce apoptosis and are selective cytotoxic for several human tumor cell lines.
AID437758Inhibition of GST-tagged human LAR2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Synthesis and biological evaluation of heterocyclic ring-substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
AID368220Cell cycle arrest in HIV1 NL4-3 infected human MT2 cells assessed as accumulation at S phase at 10 uM administered 30 mins before viral challenge measured after 24 hrs by propidium iodide staining and flow cytometry2009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Solution- and solid-phase synthesis and anti-HIV activity of maslinic acid derivatives containing amino acids and peptides.
AID1570140Anticancer activity against human A549 cells measured after 96 hrs by sulforhodamine B assay2019European journal of medicinal chemistry, Oct-15, Volume: 1802-O-(2-chlorobenzoyl) maslinic acid triggers apoptosis in A2780 human ovarian carcinoma cells.
AID1055264Induction of apoptosis in human HT-29 cells assessed as caspase-9 activation at 30 uM after 12 hrs by colorimetric assay2013European journal of medicinal chemistry, , Volume: 70Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28.
AID1074873Cytotoxicity against human 8505C cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Mar-03, Volume: 74Membrane damaging activity of a maslinic acid analog.
AID1435529Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID1055291Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay2013European journal of medicinal chemistry, , Volume: 70Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28.
AID1055272Induction of apoptosis in human HT-29 cells assessed as DNA ladder formation at 30 uM after 24 to 48 hrs by gel electrophoresis2013European journal of medicinal chemistry, , Volume: 70Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28.
AID354613Inhibition of HIV1 recombinant protease expressed in Escherichia coli DH5alpha at 17.9 ug/mL after 2 hrs by HPLC assay1996Journal of natural products, Jul, Volume: 59, Issue:7
Anti-HIV triterpene acids from Geum japonicum.
AID1431432Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID380418Cytotoxicity against human KB cells by SRB assay2006Journal of natural products, Mar, Volume: 69, Issue:3
Antimalarial compounds from Grewia bilamellata.
AID1055278Cell cycle arrest in human HT-29 cells assessed as total reduction of cells in G2/M phase at 30 uM after 48 hrs by propidium iodide staining-based FACS analysis2013European journal of medicinal chemistry, , Volume: 70Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28.
AID368222Cell cycle arrest in HIV1 NL4-3 infected human MT2 cells assessed as accumulation at G2/M phase at 10 uM administered 30 mins before viral challenge measured after 24 hrs by propidium iodide staining and flow cytometry2009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Solution- and solid-phase synthesis and anti-HIV activity of maslinic acid derivatives containing amino acids and peptides.
AID1075594Induction of apoptosis in mouse B16F10 cells assessed as normal cells at 2 X IC50 after 72 hrs by annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 77.9 +/- 1.5%)2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID1422358Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID1570143Anticancer activity against human MCF7 cells measured after 96 hrs by sulforhodamine B assay2019European journal of medicinal chemistry, Oct-15, Volume: 1802-O-(2-chlorobenzoyl) maslinic acid triggers apoptosis in A2780 human ovarian carcinoma cells.
AID1435537Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha production at 50 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID338354Inhibition of EBV-early antigen activation in human Raji cells assessed as early antigen activation at 1 uM ratio after 48 hrs
AID1055284Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay2013European journal of medicinal chemistry, , Volume: 70Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28.
AID1066417Cytotoxicity against human A549 cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Jan-24, Volume: 72The chemical and biological potential of C ring modified triterpenoids.
AID1422359Cytotoxicity against human 518A2 cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID380422Selectivity index, ratio of ED50 for human KB cells to IC50 for Plasmodium falciparum W22006Journal of natural products, Mar, Volume: 69, Issue:3
Antimalarial compounds from Grewia bilamellata.
AID1628352Cytotoxicity against human FADU cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay2016European journal of medicinal chemistry, Aug-25, Volume: 119Urea derivates of ursolic, oleanolic and maslinic acid induce apoptosis and are selective cytotoxic for several human tumor cell lines.
AID380419Antimalarial activity against Plasmodium falciparum D6 by [3H]hypoxanthine uptake2006Journal of natural products, Mar, Volume: 69, Issue:3
Antimalarial compounds from Grewia bilamellata.
AID1246451Antiinflammatory activity in IRC mouse assessed as inhibition of TPA-induced IL-6 mRNA expression in epidermis at 2 umol administered topically 30 mins prior to TPA challenge for twice weekly over 2 weeks measured 6 hrs post last TPA challenge by qRT-PCR 2015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Synthesis of oxygenated oleanolic and ursolic acid derivatives with anti-inflammatory properties.
AID1612308Inhibition of PHD (unknown origin) expressed in mouse NIH/3T3 cells harboring HRE-driven luciferase gene assessed as transactivation of HIF1alpha after 6 hrs by luciferase reporter gene assay2018Journal of natural products, 10-26, Volume: 81, Issue:10
Triterpenoid Hydroxamates as HIF Prolyl Hydrolase Inhibitors.
AID480913Inhibition of serine protease in excreted-secreted products fraction of Toxoplasma gondii RH tachyzoites infected in african green monkey Vero cells by SDS-PAGE and zymography2010Journal of natural products, May-28, Volume: 73, Issue:5
Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii.
AID1431433Cytotoxicity against human A2780 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1776683Cytotoxicity against mouse B16-F10 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay2021Journal of natural products, 05-28, Volume: 84, Issue:5
Synthesis and Biological Activity of Triterpene-Coumarin Conjugates.
AID1896214Inhibition of Bacillus licheniformis Subtilisin A2022Journal of medicinal chemistry, 10-13, Volume: 65, Issue:19
Subtilisin-like Serine Protease 1 (SUB1) as an Emerging Antimalarial Drug Target: Current Achievements in Inhibitor Discovery.
AID380420Selectivity index, ratio of ED50 for human KB cells to IC50 for Plasmodium falciparum D62006Journal of natural products, Mar, Volume: 69, Issue:3
Antimalarial compounds from Grewia bilamellata.
AID1628356Cytotoxicity against human A2780 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay2016European journal of medicinal chemistry, Aug-25, Volume: 119Urea derivates of ursolic, oleanolic and maslinic acid induce apoptosis and are selective cytotoxic for several human tumor cell lines.
AID1570139Anticancer activity against human A2780 cells measured after 96 hrs by sulforhodamine B assay2019European journal of medicinal chemistry, Oct-15, Volume: 1802-O-(2-chlorobenzoyl) maslinic acid triggers apoptosis in A2780 human ovarian carcinoma cells.
AID1435536Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-6 production at 0.4 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID1570141Anticancer activity against human DLD1 cells measured after 96 hrs by sulforhodamine B assay2019European journal of medicinal chemistry, Oct-15, Volume: 1802-O-(2-chlorobenzoyl) maslinic acid triggers apoptosis in A2780 human ovarian carcinoma cells.
AID1435539Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha production at 2 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID1066421Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Jan-24, Volume: 72The chemical and biological potential of C ring modified triterpenoids.
AID735856Antinociceptive activity in CD-1 mouse assessed as reduction of formalin-induced inflammatory pain at 1 % administered topically 15 mins challenge measured up to 5 mins2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Antiallodynic and analgesic effects of maslinic acid, a pentacyclic triterpenoid from Olea europaea.
AID587676Antibacterial activity against Pseudomonas aeruginosa as growth inhibition by liquid microdilution assay2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Triterpenoid saponins from Symplocos lancifolia.
AID1634719Antibacterial activity against Escherichia coli measured after 5 to 6 hrs by microdilution titre technique2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID1617775Inhibition of human recombinant 5-LOX expressed in insect cells assessed residual activity using arachidonic acid at 42 uM as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in dark by ferric ion oxidation-xylenol o2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID629583Induction of apoptosis in mouse B16F10 cells assessed as necrotic cells at 30 uM after 24 hrs using annexin V-FITC/propidium iodide staining by flow cytometry2011European journal of medicinal chemistry, Dec, Volume: 46, Issue:12
Maslinic acid derivatives induce significant apoptosis in b16f10 murine melanoma cells.
AID1570142Anticancer activity against human HT-29 cells measured after 96 hrs by sulforhodamine B assay2019European journal of medicinal chemistry, Oct-15, Volume: 1802-O-(2-chlorobenzoyl) maslinic acid triggers apoptosis in A2780 human ovarian carcinoma cells.
AID480910Antimicrobial activity against Toxoplasma gondii RH tachyzoites assessed as inhibition of parasite invasion of african green monkey Vero cells pretreated for 1 hr before cell infection measured 48 hrs post infection2010Journal of natural products, May-28, Volume: 73, Issue:5
Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii.
AID1075591Induction of apoptosis in mouse B16F10 cells assessed as early apoptotic cells at IC50 after 72 hrs by annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 3.9 +/- 0.4%)2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID1055266Induction of apoptosis in human HT-29 cells assessed as caspase-3 activation at 30 uM after 12 hrs by colorimetric assay2013European journal of medicinal chemistry, , Volume: 70Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28.
AID697010Inhibition of reductase activity of N-terminal 6His-tagged human recombinant AKR1B1 expressed in Escherichia coli BL21(DE3) assessed as assessed as pyridine-3-aldehyde reduction2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID1431438Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1617780Inhibition of human recombinant COX2 expressed in baculovirus infected sf21 cells assessed as decrease in PGE2 formation using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1422361Cytotoxicity against human MCF7 cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID480916Cytopathic effect against Toxoplasma gondii RH extracellular tachyzoites infected in african green monkey Vero cells assessed as induction of morphological changes at 25 uM after 8 hrs by electron microscopy2010Journal of natural products, May-28, Volume: 73, Issue:5
Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii.
AID735851Neurotoxicity in CD-1 mouse assessed as impairment in motor coordination at 512 mg/kg, sc measured up to 3 hrs by rotarod test2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Antiallodynic and analgesic effects of maslinic acid, a pentacyclic triterpenoid from Olea europaea.
AID1404181Antiviral activity against Influenza A virus H3N2 A/Hong Kong/68 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 48 hrs
AID697009Inhibition of reductase activity of N-terminal 6His-tagged human AKR1B10 expressed in Escherichia coli BL21(DE3) assessed as pyridine-3-aldehyde reduction2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID338351Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as early antigen activation at 1000 mol ratio after 48 hrs relative to TPA
AID436293Inhibition of rabbit muscle glycogen phosphorylase a assessed as glycogen synthesis2008Journal of natural products, Nov, Volume: 71, Issue:11
Practical synthesis of bredemolic acid, a natural inhibitor of glycogen phosphorylase.
AID1383850Cytotoxicity against human A549 cells after 96 hrs by sulforhodamine-B assay2018European journal of medicinal chemistry, Apr-25, Volume: 150An access to a library of novel triterpene derivatives with a promising pharmacological potential by Ugi and Passerini multicomponent reactions.
AID1456045Inhibition of RANKL-induced C57BL/6 mouse bone marrow monocytes differentiation into osteoclasts at 0.5 uM after 6 days in presence of M-CSF by tartrate-resistant acid phosphatase staining based assay relative to control2017European journal of medicinal chemistry, May-05, Volume: 131Synthesis of heterocyclic ring-fused tricyclic diterpene analogs as novel inhibitors of RANKL-induced osteoclastogenesis and bone resorption.
AID1570145Cytotoxicity against mouse NIH/3T3 cells measured after 96 hrs by sulforhodamine B assay2019European journal of medicinal chemistry, Oct-15, Volume: 1802-O-(2-chlorobenzoyl) maslinic acid triggers apoptosis in A2780 human ovarian carcinoma cells.
AID380421Antimalarial activity against Plasmodium falciparum W2 by [3H]hypoxanthine uptake2006Journal of natural products, Mar, Volume: 69, Issue:3
Antimalarial compounds from Grewia bilamellata.
AID1055286Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay2013European journal of medicinal chemistry, , Volume: 70Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28.
AID1776685Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay2021Journal of natural products, 05-28, Volume: 84, Issue:5
Synthesis and Biological Activity of Triterpene-Coumarin Conjugates.
AID736265Analgesic activity in CD-1 mouse assessed as inhibition of acetic acid-induced writhing response at 64 to 256 mg/kg, sc measured after 30 mins2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Antiallodynic and analgesic effects of maslinic acid, a pentacyclic triterpenoid from Olea europaea.
AID1286174Cytotoxic activity against mouse NIH/3T3 cells by SRB assay2015European journal of medicinal chemistry, Oct-20, Volume: 103Converting maslinic acid into an effective inhibitor of acylcholinesterases.
AID1617777Inhibition of human recombinant N-terminal His-tagged 15-LOX2 expressed in Escherichia coli assessed as residual activity at 42 uM using arachidonic acid as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in dark by2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID338358Cytotoxicity against human Raji cells assessed as cell viability at 10 mol ratio after 48 hrs relative to TPA
AID1075593Cytotoxicity against mouse B16F10 cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID1074870Cytotoxicity against human A549 cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Mar-03, Volume: 74Membrane damaging activity of a maslinic acid analog.
AID480914Inhibition of serine protease in excreted-secreted products fraction of microsomal secretion proteins of Toxoplasma gondii RH tachyzoites infected in african green monkey Vero cells by SDS-PAGE and zymography2010Journal of natural products, May-28, Volume: 73, Issue:5
Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii.
AID1075585Induction of apoptosis in mouse B16F10 cells assessed as necrotic cells at IC50 after 72 hrs by annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 4.0 +/- 0.6%)2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID1310453Cytotoxicity against mouse B16F10 cells assessed as growth inhibition after 72 hrs by MTT assay2016European journal of medicinal chemistry, Aug-08, Volume: 118Semi-synthesis and antiproliferative evaluation of PEGylated pentacyclic triterpenes.
AID1075586Induction of apoptosis in mouse B16F10 cells assessed as total apoptotic cells at 2 X IC50 after 72 hrs by annexin V-FITC/propidium iodide staining-based FACS analysis (Rvb = 13.7 +/- 2.7%)2014European journal of medicinal chemistry, Mar-03, Volume: 74Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
AID1055289Cytotoxicity against human A549 cells after 96 hrs by SRB assay2013European journal of medicinal chemistry, , Volume: 70Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28.
AID1435531Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID1055287Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay2013European journal of medicinal chemistry, , Volume: 70Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28.
AID735853Antiallodynic activity against capsaicin-induced secondary mechanical pain in sc dosed CD-1 mouse assessed as paw withdrawal-latency measured after 30 mins post compound administration2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Antiallodynic and analgesic effects of maslinic acid, a pentacyclic triterpenoid from Olea europaea.
AID1382747Growth inhibition of mouse B16F10 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Mar-25, Volume: 148Diamine and PEGylated-diamine conjugates of triterpenic acids as potential anticancer agents.
AID1628355Cytotoxicity against human A549 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay2016European journal of medicinal chemistry, Aug-25, Volume: 119Urea derivates of ursolic, oleanolic and maslinic acid induce apoptosis and are selective cytotoxic for several human tumor cell lines.
AID368217Induction of apoptosis in HIV1 NL4-3 infected human MT2 cells at 25 uM administered 30 mins before viral challenge measured after 24 hrs by propidium iodide staining and flow cytometry2009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Solution- and solid-phase synthesis and anti-HIV activity of maslinic acid derivatives containing amino acids and peptides.
AID480909Antimicrobial activity against Toxoplasma gondii RH tachyzoites assessed as inhibition of parasite invasion of african green monkey Vero cells pretreated for 1 hr before cell infection measured 24 hrs post infection2010Journal of natural products, May-28, Volume: 73, Issue:5
Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii.
AID368219Cell cycle arrest in HIV1 NL4-3 infected human MT2 cells assessed as accumulation at G0/G1 phase at 25 uM administered 30 mins before viral challenge measured after 24 hrs by propidium iodide staining and flow cytometry2009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Solution- and solid-phase synthesis and anti-HIV activity of maslinic acid derivatives containing amino acids and peptides.
AID1246449Antiinflammatory activity in IRC mouse assessed as inhibition of TPA-induced IL-1alpha mRNA expression in epidermis at 2 umol administered topically 30 mins prior to TPA challenge for twice weekly over 2 weeks measured 6 hrs post last TPA challenge by qRT2015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Synthesis of oxygenated oleanolic and ursolic acid derivatives with anti-inflammatory properties.
AID480918Antimicrobial activity against Toxoplasma gondii RH tachyzoites assessed as inhibition of parasite gliding motility at 10 uM pretreated for 15 mins2010Journal of natural products, May-28, Volume: 73, Issue:5
Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii.
AID1443716Cytotoxicity against human KB cells assessed as growth inhibition after 72 hrs by neutral red assay2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Cytotoxic dammarane-type triterpenoids from the leaves of Viburnum sambucinum.
AID1431436Cytotoxicity against human A549 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID338357Cytotoxicity against human Raji cells assessed as cell viability at 100 mol ratio after 48 hrs relative to TPA
AID1055290Cytotoxicity against human 8505C cells after 96 hrs by SRB assay2013European journal of medicinal chemistry, , Volume: 70Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28.
AID1435533Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-6 production at 50 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID1310455Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay2016European journal of medicinal chemistry, Aug-08, Volume: 118Semi-synthesis and antiproliferative evaluation of PEGylated pentacyclic triterpenes.
AID1628351Cytotoxicity against human 518A2 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay2016European journal of medicinal chemistry, Aug-25, Volume: 119Urea derivates of ursolic, oleanolic and maslinic acid induce apoptosis and are selective cytotoxic for several human tumor cell lines.
AID1443718Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by neutral red assay2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Cytotoxic dammarane-type triterpenoids from the leaves of Viburnum sambucinum.
AID1617779Inhibition of ovine recombinant COX1 assessed as residual activity at 42 uM using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1435534Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-6 production at 10 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID368218Cell cycle arrest in HIV1 NL4-3 infected human MT2 cells assessed as accumulation at G0/G1 phase at 10 uM administered 30 mins before viral challenge measured after 24 hrs by propidium iodide staining and flow cytometry2009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Solution- and solid-phase synthesis and anti-HIV activity of maslinic acid derivatives containing amino acids and peptides.
AID1456046Inhibition of RANKL-induced C57BL/6 mouse bone marrow monocytes differentiation into osteoclasts at 10 uM after 6 days in presence of M-CSF by tartrate-resistant acid phosphatase staining based assay relative to control2017European journal of medicinal chemistry, May-05, Volume: 131Synthesis of heterocyclic ring-fused tricyclic diterpene analogs as novel inhibitors of RANKL-induced osteoclastogenesis and bone resorption.
AID1246452Antiinflammatory activity in IRC mouse assessed as inhibition of TPA-induced IL-23 mRNA expression in epidermis at 2 umol administered topically 30 mins prior to TPA challenge for twice weekly over 2 weeks measured 6 hrs post last TPA challenge by qRT-PCR2015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Synthesis of oxygenated oleanolic and ursolic acid derivatives with anti-inflammatory properties.
AID1422360Cytotoxicity against human HT-29 cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID1066418Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay2014European journal of medicinal chemistry, Jan-24, Volume: 72The chemical and biological potential of C ring modified triterpenoids.
AID1404182Antiviral activity against Influenza A virus H1N1 A/Jena/8178/09 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 48 hrs
AID1570147Induction of necrosis in human A2780 cells at 30 uM measured for 72 hrs by acridine orange/propidium iodide staining based fluorescence microscopic analysis2019European journal of medicinal chemistry, Oct-15, Volume: 1802-O-(2-chlorobenzoyl) maslinic acid triggers apoptosis in A2780 human ovarian carcinoma cells.
AID587673Antibacterial activity against Staphylococcus aureus assessed as growth inhibition by liquid microdilution assay2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Triterpenoid saponins from Symplocos lancifolia.
AID1570146Induction of apoptosis in human A2780 cells assessed as membrane blebbing at 30 uM measured for 72 hrs by acridine orange/propidium iodide staining based fluorescence microscopic analysis2019European journal of medicinal chemistry, Oct-15, Volume: 1802-O-(2-chlorobenzoyl) maslinic acid triggers apoptosis in A2780 human ovarian carcinoma cells.
AID437761Selectivity, ratio of IC50 for GST-tagged human TCPTP to IC50 for GST-tagged human PTP 1B2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Synthesis and biological evaluation of heterocyclic ring-substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
AID1382753Growth inhibition of human HepG2 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Mar-25, Volume: 148Diamine and PEGylated-diamine conjugates of triterpenic acids as potential anticancer agents.
AID1570135Induction of apoptosis in human A2780 cells assessed as loss of cell membrane integrity at 30 uM measured for 72 hrs by acridine orange/propidium iodide staining based fluorescence microscopic analysis2019European journal of medicinal chemistry, Oct-15, Volume: 1802-O-(2-chlorobenzoyl) maslinic acid triggers apoptosis in A2780 human ovarian carcinoma cells.
AID1628357Cytotoxicity against human SW1736 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay2016European journal of medicinal chemistry, Aug-25, Volume: 119Urea derivates of ursolic, oleanolic and maslinic acid induce apoptosis and are selective cytotoxic for several human tumor cell lines.
AID377421Antioxidant activity assessed as DPPH-radical scavenging activity2006Journal of natural products, Jul, Volume: 69, Issue:7
Diterpenes from Leucas aspera inhibiting prostaglandin-induced contractions.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (235)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (0.43)18.2507
2000's37 (15.74)29.6817
2010's146 (62.13)24.3611
2020's51 (21.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.40 (24.57)
Research Supply Index5.49 (2.92)
Research Growth Index6.15 (4.65)
Search Engine Demand Index53.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (37.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (1.26%)5.53%
Reviews10 (4.18%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other226 (94.56%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]